{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:06:44Z","timestamp":1783984004537,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Parul University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"DOI":"10.1186\/s13065-026-01838-6","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T01:45:19Z","timestamp":1779241519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stability indicating HPLC method development and validation for the determination of organic impurities of cariprazine hydrochloride, their characterization by LC-MS and NMR techniques"],"prefix":"10.1186","volume":"20","author":[{"given":"Rajesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra Kumar","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Har Lal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amlan Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Khaturia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"2","key":"1838_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0893-133X(95)00160-F","volume":"15","author":"H Kehne","year":"1996","unstructured":"Kehne H, Ketteler HJ, McCloskey TC, Sullivan CK, Dudley MW, Schmidt CJ. Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats. Neuropsychopharmacol. 1996;15(2):116\u201324. https:\/\/doi.org\/10.1016\/0893-133X(95)00160-F.","journal-title":"Neuropsychopharmacol"},{"issue":"8","key":"1838_CR2","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.3390\/ijms22084119","volume":"22","author":"V Begni","year":"2021","unstructured":"Begni V, Sanson A, Luoni A, Sensini F, Grayson B, Munni S, Riva MA. Towards novel treatments for schizophrenia: molecular and behavioural signatures of the psychotropic agent SEP-363856. Int J Mol Sci. 2021;22(8):4119. https:\/\/doi.org\/10.3390\/ijms22084119.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1838_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/204512531667","volume":"7","author":"S Frankel","year":"2017","unstructured":"Frankel S, Schwartz TL. Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole. Ther Adv Psychopharmacol. 2017;7(1):29\u201341. https:\/\/doi.org\/10.1177\/204512531667.","journal-title":"Ther Adv Psychopharmacol"},{"issue":"3","key":"1838_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2174\/1871527321666220324121935","volume":"22","author":"A Patel","year":"2023","unstructured":"Patel A, Patel A, Patel D, Patel K, Bambharoliya T. Mini review on cariprazine: a promising antipsychotic agent. CNS Neurol Disord Drug Targets. 2023;22(3):226\u201336. https:\/\/doi.org\/10.2174\/1871527321666220324121935.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1838_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-clinpsy-032813-153657","volume":"10","author":"M Laursen","year":"2014","unstructured":"Laursen M, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Annu Rev Clin Psychol. 2014;10:425\u201348. https:\/\/doi.org\/10.1146\/annurev-clinpsy-032813-153657.","journal-title":"Annu Rev Clin Psychol"},{"issue":"5","key":"1838_CR6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.euroneuro.2013.10.016","volume":"24","author":"R Marder","year":"2014","unstructured":"Marder R, Kirkpatrick B. Defining and measuring negative symptoms of schizophrenia in clinical trials. Eur Neuropsychopharmacol. 2014;24(5):737\u201343. https:\/\/doi.org\/10.1016\/j.euroneuro.2013.10.016.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"18","key":"1838_CR7","doi-asserted-by":"publisher","first-page":"10624","DOI":"10.3390\/ijms231810624","volume":"23","author":"J Orzelska-G\u00f3rka","year":"2022","unstructured":"Orzelska-G\u00f3rka J, Mikulska J, Wiszniewska A, Bia\u0142a G. New atypical antipsychotics in the treatment of schizophrenia and depression. Int J Mol Sci. 2022;23(18):10624. https:\/\/doi.org\/10.3390\/ijms231810624.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1838_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/HRP.0000000000000275","volume":"29","author":"L Citrome","year":"2021","unstructured":"Citrome L, Volavka J. Specific anti-hostility effects of atypical antipsychotics in persons with schizophrenia: from clozapine to cariprazine. Harv Rev Psychiatry. 2021;29(1):20\u201334. https:\/\/doi.org\/10.1097\/HRP.0000000000000275.","journal-title":"Harv Rev Psychiatry"},{"issue":"1","key":"1838_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2194-7511-1-12","volume":"1","author":"J Angst","year":"2013","unstructured":"Angst J. Bipolar disorders in DSM-5: strengths, problems and perspectives. Int J Bipolar Disord. 2013;1(1):1\u20133. https:\/\/doi.org\/10.1186\/2194-7511-1-12.","journal-title":"Int J Bipolar Disord"},{"issue":"4","key":"1838_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/bdi.12850","volume":"22","author":"V Pinto","year":"2020","unstructured":"Pinto V, Saraf G, Vigo D, Keramatian K, Chakrabarty T, Yatham LN. Cariprazine in the treatment of bipolar disorder: a systematic review and meta-analysis. Bipolar Disord. 2020;22(4):360\u201371. https:\/\/doi.org\/10.1111\/bdi.12850.","journal-title":"Bipolar Disord"},{"key":"1838_CR11","doi-asserted-by":"publisher","first-page":"769897","DOI":"10.3389\/fpsyt.2021.769897","volume":"12","author":"A Do","year":"2021","unstructured":"Do A, Keramatian K, Schaffer A, Yatham L. Cariprazine in the treatment of bipolar disorder: within and beyond clinical trials. Front Psychiatry. 2021;12:769897. https:\/\/doi.org\/10.3389\/fpsyt.2021.769897.","journal-title":"Front Psychiatry"},{"issue":"2","key":"1838_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1017\/S0885715624000526","volume":"40","author":"A Kaduk","year":"2025","unstructured":"Kaduk A, Rost MM, Dosen A, Blanton TN. Crystal structure of cariprazine dihydrochloride, C21H34Cl2N4OCl2. Powder Diffr. 2025;40(2):89\u201393. https:\/\/doi.org\/10.1017\/S0885715624000526.","journal-title":"Powder Diffr"},{"issue":"5","key":"1838_CR13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/YIC.0000000000000235","volume":"33","author":"M Fava","year":"2018","unstructured":"Fava M, Durgam S, Earley W, Lu K, Hayes R, Laszlovszky I, N\u00e9meth G. Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial. Int Clin Psychopharmacol. 2018;33(5):312\u201321. https:\/\/doi.org\/10.1097\/YIC.0000000000000235.","journal-title":"Int Clin Psychopharmacol"},{"issue":"4","key":"1838_CR14","doi-asserted-by":"publisher","first-page":"e13397","DOI":"10.1111\/ijcp.13397","volume":"73","author":"L Citrome","year":"2019","unstructured":"Citrome L. Cariprazine for bipolar depression: what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? Int J Clin Pract. 2019;73(4):e13397. https:\/\/doi.org\/10.1111\/ijcp.13397.","journal-title":"Int J Clin Pract"},{"issue":"5","key":"1838_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/1040123718030004","volume":"30","author":"A Chhatlani","year":"2018","unstructured":"Chhatlani A, Farheen SA, Setty MJ, Tampi R. Use of cariprazine in psychiatric disorders: a systematic review. Ann Clin Psychiatry. 2018;30(5):326\u201334. https:\/\/doi.org\/10.1177\/1040123718030004.","journal-title":"Ann Clin Psychiatry"},{"key":"1838_CR16","unstructured":"Taddei M, Cini E, Rasparini. Marcello. Process for preparation of an antipsychotic drug Cariprazine. WO 2015056164."},{"issue":"3","key":"1838_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1021\/acs.oprd.1c00488","volume":"26","author":"Org","year":"2022","unstructured":"Org. Process Res Dev. 2022;26(3):493\u2013507. https:\/\/doi.org\/10.1021\/acs.oprd.1c00488.","journal-title":"Process Res Dev"},{"key":"1838_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-99-9283-6","volume-title":"Dictionary of toxicology","author":"B Pant","year":"2024","unstructured":"Pant B. Dictionary of toxicology. Singapore: Springer Nature; 2024. https:\/\/doi.org\/10.1007\/978-981-99-9283-6."},{"issue":"3","key":"1838_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/22297928.2023.2242857","volume":"13","author":"P Chiprikar","year":"2023","unstructured":"Chiprikar P, Mastiholimath V. Development of RP-HPLC based analytical method for determination of cariprazine hydrochloride in bulk drug and pharmaceutical dosage form using box-behnken statistical design. Anal Chem Lett. 2023;13(3):297\u2013312. https:\/\/doi.org\/10.1080\/22297928.2023.2242857.","journal-title":"Anal Chem Lett"},{"issue":"1","key":"1838_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/1570178618666210921122107","volume":"19","author":"A Singavarapu","year":"2022","unstructured":"Singavarapu A, Reddipalli GS, Ghojala VR. Synthesis of antipsychotic drug, cariprazine: an improved and commercially viable synthetic approach. Lett Org Chem. 2022;19(1):64\u201370. https:\/\/doi.org\/10.2174\/1570178618666210921122107.","journal-title":"Lett Org Chem"},{"issue":"1","key":"1838_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.25135\/jcm.68.2201.2338","volume":"28","author":"P Sushma","year":"2022","unstructured":"Sushma P, Pawar AK. Identification, separation and mass spectral characterization of degradants in cariprazine HCl by LC-MS\/MS\/QTOF. J Chem Metrol. 2022;28(1):14\u201327. https:\/\/doi.org\/10.25135\/jcm.68.2201.2338.","journal-title":"J Chem Metrol"},{"key":"1838_CR22","doi-asserted-by":"publisher","first-page":"114955","DOI":"10.1016\/j.jpba.2022.114955","volume":"219","author":"J Mohit","year":"2022","unstructured":"Mohit J, Shahnawaz K. A comprehensive forced degradation studies of cariprazine hydrochloride using LC-HRMS\/MS and in silico toxicity predictions of its degradation products. J Pharm Biomed Anal. 2022;219:114955. https:\/\/doi.org\/10.1016\/j.jpba.2022.114955.","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"1838_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.18231\/j.joapr.2024.12.2.27.34","volume":"12","author":"S Mohini","year":"2024","unstructured":"Mohini S, Rahul G, Tejas S, Onkar P, Sujata K. Stability indicating RP-HPLC method for the estimation of cariprazine hydrochloride in human plasma. J Appl Pharm Res. 2024;12(2):27\u201334. https:\/\/doi.org\/10.18231\/j.joapr.2024.12.2.27.34.","journal-title":"J Appl Pharm Res"},{"issue":"3","key":"1838_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.23880\/oajpr-16000294","volume":"8","author":"B Rushikesh","year":"2024","unstructured":"Rushikesh B, Mayur B, Sandip C, Piyush B, Jayesh G, Vijayraj S, Ganesh A. Brief review on different chromatographic techniques. Open Access J Pharm Res. 2024;8(3):294. https:\/\/doi.org\/10.23880\/oajpr-16000294.","journal-title":"Open Access J Pharm Res"},{"key":"1838_CR25","unstructured":"Lloyd S, Joseph JK, Joseph LG. Practical HPLC method development. Wiley-Interscience, New York; 1997. ISBN 0-471-00703-X."},{"issue":"3","key":"1838_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2478\/cipms-2022-0039","volume":"35","author":"K Gupta","year":"2022","unstructured":"Gupta K, Ghuge A, Parab M, Al-Refaei Y, Khandare A, Dand N, Waghmare N. A comparative review on high-performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC) & high-performance thin layer chromatography (HPTLC) with current updates. Curr Issues Pharm Med Sci. 2022;35(3):224\u20138. https:\/\/doi.org\/10.2478\/cipms-2022-0039.","journal-title":"Curr Issues Pharm Med Sci"},{"issue":"2","key":"1838_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.69613\/t4nhz921","volume":"2","author":"K Pandreka","year":"2024","unstructured":"Pandreka K, Yamini M, Abhishek G, Gope ER, Raghava D. Advances in high-performance liquid chromatography (HPLC) and ultra-performance liquid chromatography (UPLC). J Pharma Insights Res. 2024;2(2):39\u201346. https:\/\/doi.org\/10.69613\/t4nhz921.","journal-title":"J Pharma Insights Res"},{"issue":"2","key":"1838_CR28","first-page":"102","volume":"1","author":"T Gilakamsetti","year":"2025","unstructured":"Gilakamsetti T. A review of the analytical methods established for FDA approved drugs in 2022. GAMANAM. 2025;1(2):102\u201312.","journal-title":"GAMANAM"},{"key":"1838_CR29","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.89501","author":"L Narasimha","year":"2020","unstructured":"Narasimha L, Chandrasekar K. Principles of chromatographic method development. Biochem Anal Tools. 2020. https:\/\/doi.org\/10.5772\/intechopen.89501. Chap. 9.","journal-title":"Biochem Anal Tools"},{"issue":"1","key":"1838_CR30","doi-asserted-by":"publisher","first-page":"28668","DOI":"10.1038\/s41598-025-13486-2","volume":"15","author":"A Elsonbaty","year":"2025","unstructured":"Elsonbaty A, Attala K, Darweish E. Computer aided greenness by design approach for resolving and quantifying Triamterene and Hydrochlorothiazide in pharmaceutical mixtures employing multiscale dynamics simulations. Sci Rep. 2025;15(1):28668.","journal-title":"Sci Rep"},{"key":"1838_CR31","doi-asserted-by":"publisher","first-page":"105857","DOI":"10.1016\/j.microc.2020.105857","volume":"162","author":"K Attala","year":"2021","unstructured":"Attala K, Eissa MS, El-Henawee MM, Abd El-Hay SS. Application of quality by design approach for HPTLC simultaneous determination of amlodipine and celecoxib in presence of process-related impurity. Microchem J. 2021;162:105857. https:\/\/doi.org\/10.1016\/j.microc.2020.105857.","journal-title":"Microchem J"},{"issue":"3","key":"1838_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jpha.2013.09.003","volume":"4","author":"M Blessy","year":"2013","unstructured":"Blessy M, Ruchi DP, Prajesh NP, Agrawal YK. Development of forced degradation and stability indicating studies of drug \u2013 a review. J Pharm Anal. 2013;4(3):159\u201365. https:\/\/doi.org\/10.1016\/j.jpha.2013.09.003.","journal-title":"J Pharm Anal"},{"issue":"1","key":"1838_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jpba.2013.07.013","volume":"86","author":"J Deepti","year":"2013","unstructured":"Deepti J, Pawan BK. Forced degradation and impurity profiling: recent trends in analytical perspectives. J Pharm Biomed Anal. 2013;86(1):11\u201335. https:\/\/doi.org\/10.1016\/j.jpba.2013.07.013.","journal-title":"J Pharm Biomed Anal"},{"key":"1838_CR34","unstructured":"ICH Guideline. Impurities in new drug substances, Q3A (R2). Int Council Harmonisation. 2006."},{"key":"1838_CR35","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger CM, Franklin M, Oler E, Wilson A, Wishart DS. DrugBank 6.0: the DrugBank knowledge base for 2024. Nucleic Acids Res. 2024;52:D1265\u201375. https:\/\/doi.org\/10.1093\/nar\/gkad976.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1838_CR36","first-page":"91","volume":"1","author":"A Mandru","year":"2023","unstructured":"Mandru A, Mane J, Mandapati R. A review on UV-visible spectroscopy. J Pharma Insights Res. 2023;1(2):91\u20136.","journal-title":"J Pharma Insights Res"},{"key":"1838_CR37","doi-asserted-by":"publisher","unstructured":"De Caro A, Haller C. UV\/VIS spectrophotometry\u2014fundamentals and applications. Mettler-Toledo International; 2015. https:\/\/doi.org\/10.1007\/978-3-642-77477-5","DOI":"10.1007\/978-3-642-77477-5"},{"key":"1838_CR38","unstructured":"ICH Guideline. Validation of analytical procedure: text and methodology, Q2 (R2). Int Council Harmonisation. 2017."},{"issue":"8","key":"1838_CR39","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s00216-020-02465-7","volume":"412","author":"G Hellinghausen","year":"2020","unstructured":"Hellinghausen G, Wahab MF, Armstrong DW. Improving peak capacities over 100 in less than 60 seconds: operating above normal peak capacity limits with signal processing. Anal Bioanal Chem. 2020;412(8):1925\u201332. https:\/\/doi.org\/10.1007\/s00216-020-02465-7.","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"1838_CR40","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1021\/ac801772u","volume":"81","author":"X Li","year":"2009","unstructured":"Li X, Stoll DR, Carr PW. A simple and accurate equation for peak capacity estimation in two dimensional liquid chromatography. Anal Chem. 2009;81(2):845\u201350. https:\/\/doi.org\/10.1021\/ac801772u.","journal-title":"Anal Chem"},{"key":"1838_CR41","volume-title":"Introduction to modern liquid chromatography","author":"LR Snyder","year":"2010","unstructured":"Snyder LR, Kirkland JJ, Dolan JW. Introduction to modern liquid chromatography. 3rd ed. Hoboken (NJ): Wiley; 2010.","edition":"3"},{"key":"1838_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0021-9673(00)89367-7","volume":"142","author":"C Horv\u00e1th","year":"1977","unstructured":"Horv\u00e1th C, Melander W, Moln\u00e1r I. Liquid chromatography of ionogenic substances. J Chromatogr A. 1977;142:1\u201332. https:\/\/doi.org\/10.1016\/S0021-9673(00)89367-7.","journal-title":"J Chromatogr A"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-026-01838-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-026-01838-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-026-01838-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:41:39Z","timestamp":1783982499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13065-026-01838-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1838"],"URL":"https:\/\/doi.org\/10.1186\/s13065-026-01838-6","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}